Patents
US 9095504 B2: RNA interference in ocular indications
- Granted
- 2015-08-04
- Filed
- 2011-03-24 application 13636748
- Type
- Utility · 10 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
The present invention relates to ocular administration of sd-rxRNA and rxRNAori molecules.
Source: PVGPATDIS, file of 2026-04-10 (ipg150804.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| RXi Pharmaceuticals Corporation 17 patents | US company or organization | Not reported | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Lyn Libertine | Framingham, MA | 8 | PVGPATDIS, file of 2026-04-10 | |
| Anastasia Khvorova | Westborough, MA | 193 | PVGPATDIS, file of 2026-04-10 | |
| William Salomon | Worcester, MA | 35 | PVGPATDIS, file of 2026-04-10 | |
| Joanne Kamens | Newton, MA | 30 | PVGPATDIS, file of 2026-04-10 | |
| Dmitry Samarsky | Westborough, MA | 30 | PVGPATDIS, file of 2026-04-10 | |
| Tod M. Woolf | Sudbury, MA | 41 | PVGPATDIS, file of 2026-04-10 | |
| James Cardia | Franklin, MA | 23 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| C12N | Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media | C12N15/1136 | PVGPATDIS, file of 2026-04-10 |
| A61K | Preparations for medical, dental or toiletry purposes | A61K9/0048 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P7/10 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2018-12-07 | Name change Change of name | RXI PHARMACEUTICALS CORPORATION signed 2018-11-14 | PHIO PHARMACEUTICALS CORP. MARLBOROUGH, MA | 48380/9 | PASDL, file of 2026-10-15 |
| 2015-06-01 | Assignment Assignment of assignor's interest | PAVCO, PAMELA A. signed 2015-05-28 | RXI PHARMACEUTICALS CORPORATION MARLBOROUGH, MA | 35756/159 | ECORSEXC, file of 2026-09-25 |
| 2013-06-17 | Assignment Assignment of assignor's interest | CARDIA, JAMES signed 2012-11-05 LIBERTINE, LYN signed 2012-11-05 KAMENS, JOANNE signed 2012-11-08 KHVOROVA, ANASTASIA signed 2012-11-15 WOOLF, TOD M. signed 2012-12-12 SAMARSKY, DMITRY signed 2013-01-03 SALOMON, WILLIAM signed 2013-01-07 | RXI PHARMACEUTICALS CORPORATION WESTBOROUGH, MA | 30622/615 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.